Records containing: Pantothenate Kinase-Associated Neurodegeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-29A Phase 2 Study of a Vitamin Metabolite for PKAN
-
CLINICAL_TRIALS study record update · 2022-11-14The Compassionate Use of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration
-
CLINICAL_TRIALS study record update · 2020-12-29Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate Replacement Therapy, in Pantothenate Kinase-Associated Neurodegeneration (PKAN) Patients: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension
-
CLINICAL_TRIALS study record update · 2019-07-17Long-term Safety and Efficacy Study of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
-
CLINICAL_TRIALS study record update · 2019-05-23A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
- Organize your saved records without ads with Plus.